Published in Oncol Lett on April 04, 2014
Targeting Phospholipid Metabolism in Cancer. Front Oncol (2016) 0.77
Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA. BMC Genomics (2016) 0.76
ATP citrate lyase is an important component of cell growth and transformation. Oncogene (2005) 3.48
Fatty acid synthase and cancer: new application of an old pathway. Cancer Res (2006) 3.37
Choline metabolism in malignant transformation. Nat Rev Cancer (2011) 2.85
Phosphatidylcholine and choline homeostasis. J Lipid Res (2008) 2.17
Phospholipase D in cell proliferation and cancer. Mol Cancer Res (2003) 2.13
Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem (2003) 2.12
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer (2009) 2.05
The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab (2006) 2.03
Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol (2010) 2.00
Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol (2008) 1.88
Common genetic polymorphisms affect the human requirement for the nutrient choline. FASEB J (2006) 1.88
Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res (2003) 1.83
Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol (1996) 1.68
Choline metabolism and risk of breast cancer in a population-based study. FASEB J (2008) 1.51
Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival. Arch Med Res (2009) 1.47
Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol Cell Biochem (2005) 1.43
Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis. Proc Natl Acad Sci U S A (2012) 1.41
Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. Clin Cancer Res (2003) 1.18
Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma. Anticancer Res (2005) 1.11
The modulation of choline phosphoglyceride metabolism in human colon cancer. Mol Cell Biochem (1996) 1.08
Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis. Endocr Relat Cancer (2010) 1.07
Sequential synthesis and methylation of phosphatidylethanolamine promote lipid droplet biosynthesis and stability in tissue culture and in vivo. J Biol Chem (2011) 1.03
Phospholipase D meets Wnt signaling: a new target for cancer therapy. Cancer Res (2011) 1.01
Hepatic phosphatidylethanolamine N-methyltransferase, unexpected roles in animal biochemistry and physiology. J Biol Chem (2007) 1.00
Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer. NMR Biomed (2012) 0.99
Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells. J Cell Physiol (1998) 0.98
Increased fatty acid synthase activity in non-small cell lung cancer tissue is a weaker predictor of shorter patient survival than increased lipoprotein lipase activity. Arch Med Res (2010) 0.92
Structure, expression profile and alternative processing of the human phosphatidylethanolamine N-methyltransferase (PEMT) gene. Biochim Biophys Acta (2001) 0.89
Diminished expression of phosphatidylethanolamine N-methyltransferase 2 during hepatocarcinogenesis. Biochem J (1999) 0.88
Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice. Biol Chem (2006) 0.88
Metabolic insights into phospholipid function using gene-targeted mice. J Biol Chem (2005) 0.88
Lipoprotein lipase activity and gene expression in lung cancer and in adjacent noncancer lung tissue. Exp Lung Res (2007) 0.84
The role of choline in prostate cancer. Clin Biochem (2012) 0.83
Hexadecylphosphocholine inhibits phosphatidylcholine synthesis via both the methylation of phosphatidylethanolamine and CDP-choline pathways in HepG2 cells. Int J Biochem Cell Biol (2004) 0.83
Increased apolipoprotein E gene expression and protein concentration in lung cancer tissue do not contribute to the clinical assessment of non-small cell lung cancer patients. Arch Med Res (2008) 0.83
Inactivation of phosphatidylethanolamine N-methyltransferase-2 in aflatoxin-induced liver cancer and partial reversion of the neoplastic phenotype by PEMT transfection of hepatoma cells. Int J Cancer (2000) 0.77
Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate. Surg Today (1996) 0.77
Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo. Br J Cancer (1991) 0.77